Seattle, WA, United States of America

Ben Dutzar

USPTO Granted Patents = 7 

 

 

Average Co-Inventor Count = 7.8

ph-index = 7

Forward Citations = 258(Granted Patents)


Company Filing History:


Years Active: 2011-2017

Loading Chart...
Loading Chart...
Loading Chart...
7 patents (USPTO):Explore Patents

Ben Dutzar: Innovator in Anti-IL-6 Antibody Development

Introduction

Ben Dutzar, an accomplished inventor based in Seattle, WA, has made significant contributions to the field of biotechnology. With an impressive portfolio of seven patents, Dutzar specializes in the development of innovative antibodies targeting interleukin-6 (IL-6), a cytokine implicated in various diseases. His work aims to advance diagnostic and therapeutic methods for conditions associated with elevated IL-6 levels.

Latest Patents

Dutzar's latest patent focuses on "Nucleic acids encoding anti-IL-6 antibodies of defined epitopic specificity." This invention encompasses the creation of antibodies, their fragments, and humanized versions that bind specifically to IL-6. The patent also includes methods for producing such antibodies and their fragments, as well as potential applications in diagnosing and treating diseases linked to IL-6. By targeting soluble IL-6 and cell surface-associated IL-6, these antibodies may inhibit detrimental biological effects, thereby offering new pathways for therapeutic intervention.

Career Highlights

Working at Alderbio Holdings LLC, Ben Dutzar has positioned himself at the forefront of antibody innovation. His dedication to research in immunology and biotechnology has led to significant advancements in the development of therapeutic antibodies. Dutzar's inventive spirit and technical expertise have garnered attention in the scientific community, making his contributions critical for the advancement of treatments in this area.

Collaborations

Throughout his career, Dutzar has collaborated with esteemed colleagues such as Leon F Garcia-Martinez and Anne Elisabeth Carvalho Jensen. These partnerships have fostered a synergistic approach to research, enhancing the depth and breadth of their collective work in antibody development.

Conclusion

Ben Dutzar's innovative work on anti-IL-6 antibodies showcases the potential for biotechnology to address pressing health issues. With his numerous patents and collaborative spirit, Dutzar continues to impact the field significantly, paving the way for new diagnostic and therapeutic strategies that could change the lives of those affected by IL-6-related conditions. His dedication to innovation underscores the vital role inventors play in advancing scientific knowledge and improving healthcare outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…